Mundi Ventures participates in Epoch Biodesign’s $18.3m Series A Round
Today, the global venture capital firm, Mundi Ventures on behalf of Inditex, disclosed its participation in Epoch Biodesign’s $18.3m Series A funding round. The investment will help Epoch, a London-based biotech company, advance its groundbreaking enzymatic recycling technology for Nylon and PET, contributing to the global transition toward a circular economy in plastics. With a long-term vision of ultimately enabling the recycling of all plastic types, Epoch is addressing one of the most pressing environmental challenges of our time.
The Series A round was led by Extantia Capital, with participation from Lowercarbon Capital, Happiness Capital, Kibo Invest, Day One Ventures and others, alongside a $1m grant from the UK government. The funding will be used to build their first plant, expand their library of plastic-eating enzymes and begin serving some of the largest textile customers in the world from the fashion, automotive, and chemicals industries.
“Epoch's innovative and promising technology has impressive potential to revolutionize blended textile recycling,” said Óscar García Maceiras, CEO of Inditex. “This investment strengthens our commitment to advancing an innovative, circular model and driving the industry's transition toward low-impact materials.”
Epoch designs supercharged enzymes that can break down even the toughest plastics in a process similar to how leaves decompose in soil. Using AI and automated screening technology, they've created enzymes that transform mixed waste into valuable chemical products at room temperature. With over 40 partnerships across performance apparel, automotive, luxury fashion, and technical textiles, the company is demonstrating true textile-to-textile circularity at scale.
"We're proving that plastic waste isn't just a problem to solve - it's a valuable resource waiting to be unlocked." said Jacob Nathan, Founder and CEO of Epoch Biodesign. "Using the molecular precision of enzymes at an industrial scale, we’re building the solution set to make all plastics recyclable and doing so at a competitive price. This is what real circularity looks like."
Epoch joins in as the third portfolio investment alongside Inditex. Previous investments include Galy (USA), which is revolutionising cellular agriculture with lab-grown cotton, and Infinite Fiber (Finland), which transforms textile waste into high-value circular fibers.
About Epoch Biodesign
Epoch Biodesign supercharges billions of years of evolution to address humanity's waste crisis. The company combines AI, robotic automation, and advanced synthetic biology to engineer enzymes that efficiently transform waste plastics into valuable chemicals. While the world drowns in plastic, Epoch is building the foundation of a waste-free future. The company was founded in 2019 by Jacob Nathan, sparked by Nathan's high school science project exploring how microbes could break down plastic waste. Under his leadership, the company has grown to a team of 30 scientists and engineers in London. So far, Epoch has raised $34m from leading investors, including Extantia Capital, Inditex (Mundi Ventures), Lowercarbon Capital, BoxGroup, Day One Ventures and others. For more information about Epoch Biodesign, visit epochbiodesign.com.
About Mundi Ventures
Mundi Ventures is a global venture capital firm managing approximately €500m in assets. With a focus on early and growth-stage technology companies, Mundi Ventures has invested in over 60 companies worldwide. Its portfolio includes Clarity AI (Spain & USA) which works on AI-powered financial ESG reporting; Neat (France) start up focused on embedded insurance, Ole (USA), a leader in life digital insurance; Betterfly (Chile), an insurtech promoting sustainable behavior; and Twinco (Spain), which finances sustainable supply chains. Mundi Ventures is committed to support transformative companies that address critical global challenges in Sustainability, Insurance, and Deep Tech.
